Six years ago, 10-year-old Braiden was enrolled in a clinical trial for his incurable brain tumor. The “experimental” drug Antineoplaston (ANP) was the sole treating agent. He went into full remission, and suffered no toxic side effects.
An MRI recently revealed Braiden’s tumor has reoccurred. The FDA is now refusing to allow Braiden to go back on ANP even though the treatment has already proven its efficacy through his previous remission.
Many other terminal patients are also being prevented from accessing ANP.
LivingForLonger.com brings you all the latest news and information on health, longevity, liberty and quality of life. Support the site by sharing what you find! In the meantime, if you care about your health, check out Cancer Uncensored - The Book - Your step-by-step guide to cancer prevention, early detection and cancer survival.